acute myeloid leukemia with minimal differentiation
ORPHA: 988322 Treatments Available
Overview
acute myeloid leukemia (AML) in which the blasts do not show evidence of myeloid differentiation by morphology and conventional cytochemistry (WHO, 2001)
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| cytarabine Cold Chain | IV infusion, 20mg/mL, 100mg/mL; Intrathecal injection, 50mg/mL | FDA Approved, EMA Approved | 10 | 3d |
| Midostaurin Orphan | Capsule, 25 mg | FDA Approved | 3 | 14d |
Classification & Codes
Orphanet Code
ORPHA:98832acute myeloid leukemia with minimal differentiation
| Orphanet | ORPHA:98832 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO